These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 28277309)
1. Differential gene expression profiles in neurons generated from lymphoblastoid B-cell line-derived iPS cells from monozygotic twin cases with treatment-resistant schizophrenia and discordant responses to clozapine. Nakazawa T; Kikuchi M; Ishikawa M; Yamamori H; Nagayasu K; Matsumoto T; Fujimoto M; Yasuda Y; Fujiwara M; Okada S; Matsumura K; Kasai A; Hayata-Takano A; Shintani N; Numata S; Takuma K; Akamatsu W; Okano H; Nakaya A; Hashimoto H; Hashimoto R Schizophr Res; 2017 Mar; 181():75-82. PubMed ID: 28277309 [TBL] [Abstract][Full Text] [Related]
2. Methylation Analysis in Monozygotic Twins With Treatment-Resistant Schizophrenia and Discordant Responses to Clozapine. Kikuchi M; Nakazawa T; Kinoshita M; Yamamori H; Yasuda Y; Fujimoto M; Hashimoto R; Numata S Front Psychiatry; 2021; 12():734606. PubMed ID: 34616320 [TBL] [Abstract][Full Text] [Related]
3. Developmental dysregulation of excitatory-to-inhibitory GABA-polarity switch may underlie schizophrenia pathology: A monozygotic-twin discordant case analysis in human iPS cell-derived neurons. Toritsuka M; Yoshino H; Makinodan M; Ikawa D; Kimoto S; Yamamuro K; Okamura K; Akamatsu W; Okada Y; Matsumoto T; Hashimoto K; Ogawa Y; Saito Y; Watanabe K; Aoki C; Takada R; Fukami SI; Hamano-Iwasa K; Okano H; Kishimoto T Neurochem Int; 2021 Nov; 150():105179. PubMed ID: 34500023 [TBL] [Abstract][Full Text] [Related]
14. Effect size of symptom status in withdrawal of typical antipsychotics and subsequent clozapine treatment in patients with treatment-resistant schizophrenia. Pickar D; Bartko JJ Am J Psychiatry; 2003 Jun; 160(6):1133-8. PubMed ID: 12777272 [TBL] [Abstract][Full Text] [Related]
15. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand. Wheeler AJ Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732 [TBL] [Abstract][Full Text] [Related]
16. Extensive gray matter volume reduction in treatment-resistant schizophrenia. Anderson VM; Goldstein ME; Kydd RR; Russell BR Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv016. PubMed ID: 25716781 [TBL] [Abstract][Full Text] [Related]
17. An open comparison of clozapine and risperidone in treatment-resistant schizophrenia. Flynn SW; MacEwan GW; Altman S; Kopala LC; Fredrikson DH; Smith GN; Honer WG Pharmacopsychiatry; 1998 Jan; 31(1):25-9. PubMed ID: 9524981 [TBL] [Abstract][Full Text] [Related]
19. Effect of Clozapine on DNA Methylation in Peripheral Leukocytes from Patients with Treatment-Resistant Schizophrenia. Kinoshita M; Numata S; Tajima A; Yamamori H; Yasuda Y; Fujimoto M; Watanabe S; Umehara H; Shimodera S; Nakazawa T; Kikuchi M; Nakaya A; Hashimoto H; Imoto I; Hashimoto R; Ohmori T Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335437 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Chakos M; Lieberman J; Hoffman E; Bradford D; Sheitman B Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]